Sign in

CIK 0001178253

  • Non-accelerated filer
  • Smaller reporting company

SCYNEXIS INC

Sign in to watch
Ticker
SCYX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
562181648
Phone
+1 201-884-5485
Business address
1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2014-05-07 KIRBY PAMELA J Director Option exercise +12,745 $0.20 $3K 12,745
2014-05-07 KIRBY PAMELA J Director Conversion +12,745 25,590
2014-05-07 KIRBY PAMELA J Director Option exercise · Common Stock Warrant (right to buy) −12,745 0
2014-05-07 KIRBY PAMELA J Director Conversion · Series D-2 Preferred Stock −260,000 0
2014-05-07 Ventech Capital II 10% owner Option exercise +14,005 $0.20 $3K 14,005
2014-05-07 Ventech Capital II 10% owner Option exercise +14,005 $0.20 $3K 28,010
2014-05-07 Ventech Capital II 10% owner Option exercise +43,704 $0.20 $9K 71,714
2014-05-07 Ventech Capital II 10% owner Conversion +30,930 102,644
2014-05-07 Ventech Capital II 10% owner Conversion +96,294 198,938
2014-05-07 Ventech Capital II 10% owner Conversion +39,685 238,623
2014-05-07 Ventech Capital II 10% owner Conversion +147,588 386,211
2014-05-07 Ventech Capital II 10% owner Purchase +28,000 $10.00 $280K 414,211
2014-05-07 Ventech Capital II 10% owner Option exercise · Common Stock Warrant (right to buy) −14,005 0
2014-05-07 Ventech Capital II 10% owner Option exercise · Common Stock Warrant (right to buy) −14,005 0
2014-05-07 Ventech Capital II 10% owner Option exercise · Common Stock Warrant (right to buy) −43,704 0
2014-05-07 Ventech Capital II 10% owner Conversion · Series B Preferred Stock −109,879 0
2014-05-07 Ventech Capital II 10% owner Conversion · Series C Preferred Stock −340,509 0
2014-05-07 Ventech Capital II 10% owner Conversion · Series D-1 Preferred Stock −809,584 0
2014-05-07 Ventech Capital II 10% owner Conversion · Series D-2 Preferred Stock −3,010,807 0
2014-05-07 Ribeill Yves J President and CEO Option exercise +595 $0.20 $119 595

Page 25 of 26 · 507 trades